Injective [INJ] posted a 13.68% recovery over the past 24 hours as buyers returned after defending a crucial support area near $4.19.
The rebound lifted Injective to around $4.89 and pushed its market capitalization to $489.67 million despite a slight decline in trading volume.
Trading activity reached $145.85 million, down 1.16% over the same period. Even so, the recovery encouraged traders to reassess the recent downtrend after INJ produced a strong bounce from its latest lows.
Why are top traders still betting against INJ?
Price recovered strongly, yet Binance’s top traders maintained a bearish stance throughout the rally. Long accounts represented just 41.09%, while 58.91% of accounts remained short, producing a Long/Short Ratio of 0.70.
The imbalance suggested many experienced traders expected the recovery to lose strength despite the double-digit gain.
Despite that, the continued short positioning also increased the possibility of additional buying pressure if the price continued higher. A sustained move beyond nearby resistance could have forced bearish traders to close positions, adding fuel to the advance.
Until that happens, however, the market continues to reflect caution rather than broad bullish conviction among leveraged participants.
Buyers returned, but sellers still controlled order flow
Derivatives data presented a mixed picture despite the strong recovery.
The Futures Volume Bubble Map entered an overheating phase, showing trading activity accelerated rapidly as price rebounded from support.
Rising participation often reflects stronger interest from both buyers and sellers rather than directional certainty. However, the Futures Taker CVD remained seller dominant, indicating market sell orders continued to outweigh aggressive buying activity during the recent recovery.
Now, the rally depends heavily on sustained Spot demand to overcome persistent selling pressure before another leg higher can develop.
Can buyers reclaim the $5 barrier?
INJ rebounded sharply after defending the $4.19 support level and climbed toward the psychological $5.00 resistance.
The daily chart showed buyers regained control after several sessions of decline, although price still traded beneath the previous swing highs around $5.68 and $7.00.
Meanwhile, the Relative Strength Index recovered to 46.67 after recently approaching oversold territory, showing bearish pressure eased considerably without entering bullish territory.
The RSI moving average stood near 44.92, reinforcing the improving structure as buying interest returned. If buyers maintain the current recovery and reclaim $5, the next upside objective could emerge around $5.68.
Failure to secure that level could encourage another retest of $4.19 before a stronger recovery develop.
Will Injective reach $7 next?
INJ recovered convincingly from an important support zone, although several signals still reflected cautious market sentiment.
Top traders continued favoring short positions, while taker activity remained seller-dominant despite the rebound.
If buyers reclaim $5 with sustained demand, the price could extend toward $5.68 before challenging $7.00.
Final Summary
- INJ recovered strongly from key support, yet bearish trader positioning continued limiting confidence.
- A break above $5 could strengthen the recovery, while rejection may revive selling pressure.
